Shares of 5N Plus Inc. (TSE:VNP – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as C$18.58 and last traded at C$17.79, with a volume of 425342 shares trading hands. The stock had previously closed at C$17.58.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on the stock. National Bank Financial raised shares of 5N Plus to a “strong-buy” rating in a research note on Thursday, June 12th. Ventum Financial lifted their target price on shares of 5N Plus from C$11.00 to C$14.00 and gave the company a “buy” rating in a research note on Thursday, July 24th. Desjardins boosted their price objective on shares of 5N Plus from C$11.00 to C$14.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Finally, Cormark raised shares of 5N Plus from a “moderate buy” rating to a “strong-buy” rating in a research note on Thursday, September 25th. Three research analysts have rated the stock with a Strong Buy rating and three have issued a Buy rating to the company’s stock. Based on data from MarketBeat, 5N Plus presently has an average rating of “Strong Buy” and a consensus price target of C$12.83.
Read Our Latest Research Report on VNP
5N Plus Trading Up 1.2%
5N Plus Company Profile
5N+ is a leading global producer of specialty semiconductors and performance materials. The Company’s ultra pure materials often form the core element of its customers’ products. These customers rely on 5N+’s products to enable performance and sustainability in their own products. 5N+ deploys a range of proprietary and proven technologies to develop and manufacture its products.
Recommended Stories
- Five stocks we like better than 5N Plus
- Investing in Travel Stocks Benefits
- 3 REITs to Watch as Rate Cuts Ignite a Real Estate Super Cycle
- Financial Services Stocks Investing
- 2 Defense Stocks Riding 2025’s Massive Momentum Wave
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Receive News & Ratings for 5N Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 5N Plus and related companies with MarketBeat.com's FREE daily email newsletter.